253 related articles for article (PubMed ID: 20216233)
21. Vincristine-induced vocal cord paralysis in a patient with acute lymphoblastic leukemia.
Bacon LC; Barnett MJ; Abou Mourad YR
Ann Hematol; 2012 Jun; 91(6):971-2. PubMed ID: 21976108
[No Abstract] [Full Text] [Related]
22. Vincristine-induced bilateral vocal cord paralysis in children.
Ahmed A; Williams D; Nicholson J
Pediatr Blood Cancer; 2007 Feb; 48(2):248. PubMed ID: 16609949
[No Abstract] [Full Text] [Related]
23. Vincristine-related neuropathy versus acute inflammatory demyelinating polyradiculoneuropathy in children with acute lymphoblastic leukemia.
Brigo F; Balter R; Marradi P; Ferlisi M; Zaccaron A; Fiaschi A; Frasson E; Bertolasi L
J Child Neurol; 2012 Jul; 27(7):867-74. PubMed ID: 22241706
[TBL] [Abstract][Full Text] [Related]
24. Vincristine-induced peripheral neuropathy in survivors of childhood acute lymphoblastic leukaemia.
Tay CG; Lee VWM; Ong LC; Goh KJ; Ariffin H; Fong CY
Pediatr Blood Cancer; 2017 Aug; 64(8):. PubMed ID: 28139029
[TBL] [Abstract][Full Text] [Related]
25. Itraconazole-enhanced vincristine neurotoxicity in a child with acute lymphoblastic leukemia.
Jeng MR; Feusner J
Pediatr Hematol Oncol; 2001 Mar; 18(2):137-42. PubMed ID: 11255732
[TBL] [Abstract][Full Text] [Related]
26. Dose-related vincristine-induced peripheral neuropathy with unexpected off-therapy worsening.
Verstappen CC; Koeppen S; Heimans JJ; Huijgens PC; Scheulen ME; Strumberg D; Kiburg B; Postma TJ
Neurology; 2005 Mar; 64(6):1076-7. PubMed ID: 15781834
[TBL] [Abstract][Full Text] [Related]
27. The Pharmacogenomics of Vincristine-Induced Neuropathy: On Pins and Needles.
Berg SL; Parsons DW
JAMA Oncol; 2015 Oct; 1(7):975-6. PubMed ID: 26181361
[No Abstract] [Full Text] [Related]
28. Vincristine induced cranial polyneuropathy.
Bay A; Yilmaz C; Yilmaz N; Oner AF
Indian J Pediatr; 2006 Jun; 73(6):531-3. PubMed ID: 16816519
[TBL] [Abstract][Full Text] [Related]
29. Experience with vincristine--associated neurotoxicity.
Othieno-Abinya NA; Nyabola LO
East Afr Med J; 2001 Jul; 78(7):376-8. PubMed ID: 11957264
[TBL] [Abstract][Full Text] [Related]
30. Vincristine-induced neuropathy in pediatric patients with acute lymphoblastic leukemia in Oman: Frequent autonomic and more severe cranial nerve involvement.
Nazir HF; AlFutaisi A; Zacharia M; Elshinawy M; Mevada ST; Alrawas A; Khater D; Jaju D; Wali Y
Pediatr Blood Cancer; 2017 Dec; 64(12):. PubMed ID: 28623857
[TBL] [Abstract][Full Text] [Related]
31. [Therapeutic response to pyridoxine and pyridostigmine in a paediatric case of severe peripheral and cranial polyneuropathy due to vincristine].
Berenguer-Potenciano M; Villora-Morcillo N; Nunez-Enamorado N; Perez-Alonso V; Camacho-Salas A; Simon-De Las Heras R
Rev Neurol; 2015 Jan; 60(2):91-2. PubMed ID: 25583593
[No Abstract] [Full Text] [Related]
32. Modification of vincristine dosing during concomitant azole therapy in adult acute lymphoblastic leukemia patients.
Harnicar S; Adel N; Jurcic J
J Oncol Pharm Pract; 2009 Sep; 15(3):175-82. PubMed ID: 19282418
[TBL] [Abstract][Full Text] [Related]
33. Lack of association of the CEP72 rs924607 TT genotype with vincristine-related peripheral neuropathy during the early phase of pediatric acute lymphoblastic leukemia treatment in a Spanish population.
Gutierrez-Camino A; Martin-Guerrero I; Lopez-Lopez E; Echebarria-Barona A; Zabalza I; Ruiz I; Guerra-Merino I; Garcia-Orad A
Pharmacogenet Genomics; 2016 Feb; 26(2):100-2. PubMed ID: 26618658
[TBL] [Abstract][Full Text] [Related]
34. Regarding "Intrathecal vincristine: 3 fatal cases and a review of the literature".
Walter AW
J Pediatr Hematol Oncol; 2010 May; 32(4):336-7. PubMed ID: 20445422
[No Abstract] [Full Text] [Related]
35. Vincristine neuropathy: neurophysiological and genetic studies in a case of Wilms tumor.
Schiavetti A; Frascarelli M; Uccini S; Novelli A
Pediatr Blood Cancer; 2004 Oct; 43(5):606-9. PubMed ID: 15382281
[TBL] [Abstract][Full Text] [Related]
36. Mild axonal neuropathy of children during treatment for acute lymphoblastic leukaemia.
Reinders-Messelink HA; Van Weerden TW; Fock JM; Gidding CE; Vingerhoets HM; Schoemaker MM; Göeken LN; Bökkerink JP; Kamps WA
Eur J Paediatr Neurol; 2000; 4(5):225-33. PubMed ID: 11030069
[TBL] [Abstract][Full Text] [Related]
37. Genetic Variants Associated With Vincristine-Induced Peripheral Neuropathy in Two Populations of Children With Acute Lymphoblastic Leukemia.
Li L; Sajdyk T; Smith EML; Chang CW; Li C; Ho RH; Hutchinson R; Wells E; Skiles JL; Winick N; Martin PL; Renbarger JL
Clin Pharmacol Ther; 2019 Jun; 105(6):1421-1428. PubMed ID: 30506673
[TBL] [Abstract][Full Text] [Related]
38. Vincristine-induced unilateral ptosis in a child.
Gursel O; Sari E; Altun D; Atay AA; Akin R
Pediatr Neurol; 2009 Dec; 41(6):461-3. PubMed ID: 19931172
[TBL] [Abstract][Full Text] [Related]
39. Incidence of vincristine induced neurotoxicity in children with acute lymphoblastic leukemia and its correlation with nutritional deficiencies.
Dudeja S; Gupta S; Sharma S; Jain A; Sharma S; Jain P; Aneja S; Chandra J
Pediatr Hematol Oncol; 2019 Sep; 36(6):344-351. PubMed ID: 31514565
[TBL] [Abstract][Full Text] [Related]
40. Precision medicine to improve the risk and benefit of cancer care: genetic factors in vincristine-related neuropathy.
McLeod HL
JAMA; 2015 Feb; 313(8):803-4. PubMed ID: 25710656
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]